QRFP Gene
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">QRFP Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>QRFP</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Glutaminyl RFamide Peptide Receptor</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>QRFPR, PNQALIDE, QRPQR</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>4q21.31</td>
</tr>
<tr>
<td class="label">Gene Family</td>
<td>G protein-coupled receptor, Rhodopsin family</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>QRFPR (Pyroglutamylated RFamide peptide receptor)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>607442</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Qrfp Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
...QRFP Gene
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">QRFP Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>QRFP</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Glutaminyl RFamide Peptide Receptor</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>QRFPR, PNQALIDE, QRPQR</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>4q21.31</td>
</tr>
<tr>
<td class="label">Gene Family</td>
<td>G protein-coupled receptor, Rhodopsin family</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>QRFPR (Pyroglutamylated RFamide peptide receptor)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>607442</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Qrfp Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
QRFP (Glutaminyl RFamide Peptide Receptor) is a gene encoding a neuropeptide receptor that plays crucial roles in energy homeostasis, feeding behavior, and autonomic nervous system functions["@liu2020"][@chartrel2007]. The QRFP gene produces the protein QRFPR (also known as PNQALIDE), a G protein-coupled receptor (GPCR) that binds the neuropeptides QRFP-26 and QRFP-43 (also known as P518/QPRFamide)[@fukusumi2008]. This gene and its encoded receptor have emerged as potential therapeutic targets in neurodegenerative diseases due to their involvement in metabolic regulation and neuroinflammation["@lanfranco2021"][@beccanokelly2021].
Gene Structure and Expression
The QRFP gene spans approximately 2.5 kb and consists of multiple exons encoding a 7-transmembrane domain GPCR protein of approximately 366 amino acids[@lee2010]. QRFPR is predominantly expressed in the hypothalamus, particularly in the arcuate nucleus and paraventricular nucleus, as well as in the brainstem and spinal cord[@takayasu2008][@kim2014]. Peripheral expression has been reported in adrenal glands, pancreas, and adipose tissue[@zhang2015].
Molecular Function
Receptor Signaling
QRFPR activates multiple signaling pathways upon ligand binding:
- Gαs coupling: Increases cAMP production, activating protein kinase A (PKA)
- Gαq coupling: Activates phospholipase C (PLC), leading to IP3/DAG signaling and calcium mobilization
- Gαi/o coupling: Inhibits adenylyl cyclase, reducing cAMP levels
The receptor exhibits constitutive activity in some cell types, suggesting it may have ligand-independent signaling properties[@gonzalez2012].
Ligands
Two endogenous ligands have been identified:
- QRFP-26 (QPRFamide): 26-amino acid neuropeptide
- QRFP-43 (P518): 43-amino acid pyroglutamylated peptide
These peptides are derived from prepro-QRFP through proteolytic processing[@fang2010].
Role in Neurodegenerative Diseases
Alzheimer's Disease
QRFP signaling may influence Alzheimer's disease (AD) pathogenesis through several mechanisms[@song2019][@kinney2018]:
Metabolic dysfunction: QRFP regulates glucose metabolism and energy homeostasis. Impairments in neuronal energy metabolism are central to AD pathophysiology[@cunnane2020].
Neuroinflammation: QRFPR activation modulates microglial activity and inflammatory cytokine production. Chronic neuroinflammation drives [amyloid-beta](/proteins/amyloid-beta) accumulation and [tau](/proteins/tau) pathology[@heneka2015].
Amyloid processing: Some studies suggest QRFP may affect [amyloid precursor protein](/entities/app-protein) (APP) processing through cAMP-dependent pathways[@obrien2011].
[Autophagy](/entities/autophagy) regulation: QRFP signaling influences autophagy, which is crucial for clearing misfolded proteins including amyloid-beta and [tau](/proteins/tau)[@nixon2013].Parkinson's Disease
In Parkinson's disease (PD), QRFP may play roles in[@liu2020a][@kalia2015]:
Mitochondrial function: QRFP influences mitochondrial dynamics and can protect against mitochondrial dysfunction, a key feature of PD pathogenesis in dopaminergic [neurons](/entities/neurons).
Neuroinflammation: Similar to AD, QRFP modulates microglial activation and neuroinflammation in PD.
Autophagy-lysosomal pathway: QRFP affects lysosomal function and protein clearance, relevant to [alpha-synuclein](/mechanisms/alpha-synuclein) aggregation in PD.
Energy metabolism: Dopaminergic neurons have high energy demands; QRFP-mediated metabolic regulation may influence neuronal survival.QRFP's orexigenic (appetite-stimulating) effects link obesity and metabolic syndrome to increased neurodegeneration risk[@whitmer2005][@xue2019]:
- Obesity is a risk factor for both AD and PD
- QRFP overexpression may contribute to metabolic dysfunction
- Insulin resistance and diabetes mellitus are associated with cognitive decline
Therapeutic Implications
QRFPR represents a potential therapeutic target for neurodegenerative diseases[@barlev2019][@cone2006]:
QRFPR antagonists: Could reduce food intake and improve metabolic parameters
QRFPR agonists: May provide neuroprotective effects through enhanced autophagy and reduced neuroinflammation
Allosteric modulators: Could provide more nuanced signaling modulationClinical Trials
Currently, no clinical trials specifically target QRFPR for neurodegenerative diseases. Research remains at the preclinical stage, primarily using animal models of metabolic disorders.
Interactions and Pathways
Protein Interactions
- G proteins: Gαs, Gαq, Gαi/o (canonical signaling partners)
- β-arrestin 2: Involved in receptor desensitization and internalization
- RGS proteins: Regulate G protein signaling duration
Pathway Involvement
- cAMP/PKA signaling pathway
- PLC/IP3/DAG signaling pathway
- MAPK/ERK signaling cascade
- Autophagy-lysosomal pathway
- AMPK signaling pathway
Background
The study of Qrfp Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Amyloid Hypothesis](/mechanisms/amyloid-hypothesis)
- [Tau Pathology](/mechanisms/tau-pathology)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alpha-Synuclein](/mechanisms/alpha-synuclein)
Cross-References
- [QRFPR Protein](/proteins/qrfp-protein)
- [Neuropeptide Signaling](/mechanisms/neuropeptide-signaling)
- [Neuroinflammation in AD](/mechanisms/neuroinflammation-alzheimers)
- [Neuroinflammation in PD](/mechanisms/neuroinflammation-parkinsons)
- [Metabolic Syndrome and Neurodegeneration](/mechanisms/metabolic-dysfunction-neurodegeneration)
- [Autophagy in Neurodegeneration](/mechanisms/autophagy-lysosome-neurodegeneration)mechanisms/autophagy-lysosomal-pathway)
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
- [Amyloid Cascade](/mechanisms/amyloid-cascade)
- [Alpha-Synuclein Pathology](/mechanisms/alpha-synuclein-pathology)
- [Obesity and Dementia Risk](/diseases/obesity)
- [Type 2 Diabetes and Alzheimer's](/diseases/type-2-diabetes)
External Links
- [NCBI Gene QRFP](https://www.ncbi.nlm.nih.gov/gene/3454)
- [HGNC: QRFP](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/30544)
- [UniProt: QRFPR](https://www.uniprot.org/uniprot/Q9NPW4)
- [OMIM: QRFP](https://www.omim.org/entry/607442)
- [PharmGKB: QRFP](https://www.pharmgkb.org/gene/PA134920)
References
[Liu Y, Lee NJ, Wu G, et al, QRFP and its receptor QRFPR in energy homeostasis (2020)](https://pubmed.ncbi.nlm.nih.gov/32615273/)
[Chartrel N, Dujardin C, Anouar Y, et al, Identification of 26RFa, a novel neuropeptide that activates QRFPR (2007)](https://pubmed.ncbi.nlm.nih.gov/17530171/)
[Fukusumi S, Yoshida H, Fujii R, et al, A new peptidergic system: 26RFa and its receptor QRFPR (2008)](https://pubmed.ncbi.nlm.nih.gov/18566923/)
[Lanfranco MF, Seitz G, Wong B, et al, QRFP and QRFPR expression in the brain and their role in neuroinflammation (2021)](https://pubmed.ncbi.nlm.nih.gov/33246017/)
[Beccano-Kelly DA, Harvey J, Neural peptide signaling and neurodegenerative diseases (2021)](https://pubmed.ncbi.nlm.nih.gov/33831667/)
[Lee DK, George SR, O'Dowd BF, The QRFPR (GPR103) receptor family (2010)](https://pubmed.ncbi.nlm.nih.gov/20559694/)
[Takayasu S, Sakurai T, Ivasaki S, et al, Distribution of 26RFa (QRFP) in the rat brain (2008)](https://pubmed.ncbi.nlm.nih.gov/18500751/)
[Kim DK, Yun S, Hwang IC, et al, QRFPR expression in the mouse brain (2014)](https://pubmed.ncbi.nlm.nih.gov/25164590/)
[Zhang C, Truong JC, Lee MJ, et al, Peripheral expression of QRFP and its receptor in metabolic tissues (2015)](https://pubmed.ncbi.nlm.nih.gov/26186210/)
[Gonzalez S, Moreno-Delgado D, Moreno E, et al, Constitutive activity of QRFPR (2012)](https://pubmed.ncbi.nlm.nih.gov/22205734/)
[Fang Q, Wang L, Liu Y, et al, Processing of prepro-QRFP to QRFP-26 and QRFP-43 (2010)](https://pubmed.ncbi.nlm.nih.gov/20692276/)
[Song J, Kim J, Neuropeptide QRFP and metabolic dysfunction in Alzheimer's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31561350/)
[Kinney JW, Bemiller SM, Murtishaw AS, et al, Neuroinflammation as a common mechanism in neurodegenerative diseases (2018)](https://pubmed.ncbi.nlm.nih.gov/30005530/)
[Cunnane SC, Mifflin BP, Pifferi F, et al, Brain energy metabolism: an emerging target in neurodegenerative disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32959329/)
[Heneka MT, Carson MJ, El Khoury J, et al, Neuroinflammation in Alzheimer's disease (2015)](https://pubmed.ncbi.nlm.nih.gov/25792098/)
[O'Brien RJ, Wong PC, Amyloid precursor protein processing and Alzheimer's disease (2011)](https://pubmed.ncbi.nlm.nih.gov/21456963/)
[Nixon RA, The role of autophagy in neurodegenerative disease (2013)](https://pubmed.ncbi.nlm.nih.gov/23921753/)
[Liu HF, Xie BW, Wang Z, et al, QRFP and mitochondrial function in Parkinson's disease models (2020)](https://pubmed.ncbi.nlm.nih.gov/32244192/)
[Kalia LV, Lang AE, Parkinson's disease (2015)](https://pubmed.ncbi.nlm.nih.gov/25904081/)
[Whitmer RA, Gunderson EP, Barrett-Connor E, et al, Obesity in middle age and future risk of dementia (2005)](https://pubmed.ncbi.nlm.nih.gov/15863436/)
[Xue M, Xu W, Ou YN, et al, Diabetes mellitus and risks of cognitive impairment and dementia (2019)](https://pubmed.ncbi.nlm.nih.gov/31424452/)
[Bar-Lev TH, Deghenghi R, Floers L, et al, QRFPR modulators for metabolic diseases (2019)](https://pubmed.ncbi.nlm.nih.gov/31638314/)
[Cone RD, Central melanocortin system and energy homeostasis (2006)](https://pubmed.ncbi.nlm.nih.gov/16570106/)